Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.
BRISBANE, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated...
BRISBANE, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated...
BRISBANE, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated...
BRISBANE, Calif., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated...
BRISBANE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated...
Broad agreement on pivotal Phase 3 study plan, including use of current amezalpat dose and scheduleOverall survival, the strongest result from the Phase 2 trial, will be the primary study...
Β Unveiled new positive survival data for amezalpat (TPST-1120) in randomized first-line hepatocellular carcinoma (βHCCβ) study demonstrating: Survival benefit maintained across key...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0201 | 1.51127819549 | 1.33 | 1.54 | 1.33 | 461154 | 1.44605848 | CS |
4 | -0.1399 | -9.38926174497 | 1.49 | 1.54 | 1.12005 | 447514 | 1.3589112 | CS |
12 | -0.8299 | -38.0688073394 | 2.18 | 2.31 | 0.9241 | 2547262 | 1.52675339 | CS |
26 | -2.3899 | -63.9010695187 | 3.74 | 6 | 0.9241 | 1850120 | 2.19650025 | CS |
52 | 0.8626 | 176.943589744 | 0.4875 | 9.77 | 0.17 | 3862346 | 5.08299044 | CS |
156 | -13.2499 | -90.752739726 | 14.6 | 15.6669 | 0.17 | 1358913 | 4.95630262 | CS |
260 | -12.4599 | -90.2237509051 | 13.81 | 41 | 0.17 | 1313287 | 5.53762163 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.